Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Drug side effects

FDA issues warning over loperamide heart risks

Loperamide (also marketed as Imodium)

Source: Wikimedia Commons / Kristoferb

The US Food and Drug Administration says the most reported cases of serious heart problems with loperamide involved doses much higher than the recommended dose

The US Food and Drug Administration (FDA) has issued a warning that high doses of the antidiarrheal medication loperamide are associated with a risk of heart problems.

The FDA says that healthcare professionals should be aware that higher-than-recommended doses can cause serious cardiac events, including QT interval prolongation, Torsades de Pointes or other ventricular arrhythmias, syncope and cardiac arrest. It also encourages them to consider loperamide, also known by the brand name Imodium, as a possible cause of unexplained cardiac events.

Additionally, the US medicines regulator warns that the risk of serious heart problems can be increased by interactions between loperamide and other drugs, such as some antibiotics and antifungals.

A recent article in the Annals of Emergency Medicine[1] (online, 29 April 2016) highlighted a growing issue of loperamide abuse by people with opioid addiction. The drug, an opioid agonist, has no central nervous system effects at therapeutic doses, but at higher doses might induce euphoria.

The paper outlined two cases where patients had died after using supratherapeutic doses of the drug to manage symptoms of opioid withdrawal. Some people also use loperamide to attempt to self-treat opioid addiction, the authors say.

The FDA says that most reported cases of serious heart problems with loperamide involved doses much higher than the recommended dose. It advises healthcare professionals to counsel patients on the importance of taking only the recommended dose and the risk of cardiac adverse events, as well as potential drug interactions.

Loperamide has been authorised for use in the UK since 1975.

A spokesperson for the Medicines and Healthcare products Regulatory Agency, the UK medicines regulator, says: “We are aware of the safety warning issued by the FDA about the abuse and misuse of loperamide (Imodium). We will consider what implications this may have for UK public health.” 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201302

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • MCQs in Clinical Pharmacy

    MCQs in Clinical Pharmacy

    Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.

    £25.00Buy now
  • Health Economics

    Health Economics

    Health Economics is a practical analysis of the prominent economic issues facing the American health care system, and what mechanisms exist to counter it.

    £33.00Buy now
  • Developing Your Prescribing Skills

    Developing Your Prescribing Skills

    Developing Your Prescribing Skills uses case studies, mind maps and feedback from experienced prescribers. It supplies practical advice on the issues facing prescribers in all types of practice.

    £23.00Buy now
  • Integrated Pharmacy Case Studies

    Integrated Pharmacy Case Studies

    Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.

    £47.00Buy now
  • Non-prescription Medicines

    Non-prescription Medicines

    Reviews over-the-counter medicines, arranged by the conditions they are licensed to treat. Includes product recommendations.

    £38.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Loperamide (also marketed as Imodium)

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.